Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of functional electrical stimulation of lower limb muscles on circulating endothelial progenitor cells, CD34+ cells and vascular endothelial growth factor-A in heart failure with reduced ejection fraction.
Magkoutis N, Mantzaraki V, Farmakis D, Spathis A, Foukas P, Bistola V, Bakosis G, Konstantoudakis S, Trogkanis E, Papingiotis G, Hatziagelaki E, Ikonomidis I, Karavidas A, Filippatos G, Parissis J. Magkoutis N, et al. Among authors: hatziagelaki e. Eur J Heart Fail. 2018 Jul;20(7):1162-1163. doi: 10.1002/ejhf.1176. Epub 2018 Mar 14. Eur J Heart Fail. 2018. PMID: 29542237 Free article. No abstract available.
A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia.
Gerasimou C, Tsoporis JN, Siafakas N, Hatziagelaki E, Kallergi M, Chatziioannou SN, Parker TG, Parissis J, Salpeas V, Papageorgiou C, Rizos E. Gerasimou C, et al. Among authors: hatziagelaki e. CNS Neurol Disord Drug Targets. 2018;17(5):383-388. doi: 10.2174/1871527317666180605120244. CNS Neurol Disord Drug Targets. 2018. PMID: 29875007
Effect of hyperthyroidism on clearance and secretion of glucagon in man.
Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE, Raptis SA. Dimitriadis G, et al. Among authors: hatziagelaki e. Exp Clin Endocrinol Diabetes. 2011 Apr;119(4):214-7. doi: 10.1055/s-0030-1269880. Epub 2011 Jan 24. Exp Clin Endocrinol Diabetes. 2011. PMID: 21264806
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
79 results